ArticleExperimental biology and medicine (Maywood, N.J.)2018

SREBP2 contributes to cisplatin resistance in ovarian cancer cells.

Lei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.